Close Menu

Researchers at the Weill Cornell Medical College in New York and their colleagues this week present "an enhanced form of reduced representation bisulfite sequencing with extended genomic coverage, which [results] in greater capture of DNA methylation information of regions lying outside of traditional CpG islands." Applying this RRBS-based approach to primary human bone marrow specimens from patients with acute myelogeneous leukemia, the researchers found that "genetically distinct AML subtypes display

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.